These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36624390)

  • 21. Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children.
    Lim JH; Kim JY; Han DH; Lee CH; Hong SN; Wee JH; Park SK; Rhee CS
    PLoS One; 2017; 12(8):e0182295. PubMed ID: 28806766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and cytokine responses to house dust mite sublingual immunotherapy.
    Potter PC; Baker S; Fenemore B; Nurse B
    Ann Allergy Asthma Immunol; 2015 Apr; 114(4):327-34. PubMed ID: 25661658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis.
    Zhong H; Fan XL; Yu QN; Qin ZL; Chen D; Xu R; Chen DH; Lin ZB; Wen W; Fu QL
    Clin Immunol; 2017 Oct; 183():293-299. PubMed ID: 28917723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Cell Alterations and PI3K-PKB Pathway Suppression in Patients with Allergic Rhinitis Undergoing Sublingual Immunotherapy.
    Zhang X; Wu G; Ma X; Cheng L
    Adv Ther; 2024 Feb; 41(2):777-791. PubMed ID: 38169061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
    Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
    Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis.
    Fan DC; Wang XD; Wang CS; Wang Y; Cao FF; Zhang L
    Chin Med J (Engl); 2016 Dec; 129(23):2824-2828. PubMed ID: 27900996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis.
    Pan Y; Zhang X; Geng H; Yu Y; Liu J; Li M; Yang H; Yuan Y; Xu Y; Wu Y; Wu G; Ma X; Cheng L
    Adv Ther; 2024 Apr; 41(4):1698-1710. PubMed ID: 38443650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Periostin as a Biomarker for Predicting Clinical Response to House Dust Mite Sublingual Immunotherapy in Allergic Rhinitis.
    Hoshino M; Akitsu K; Kubota K; Ohtawa J
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1864-1870. PubMed ID: 33290915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
    J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
    Demoly P; Kleine-Tebbe J; Rehm D
    Allergy; 2017 Oct; 72(10):1576-1578. PubMed ID: 28273339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of leptin/ILC2 axis in allergic rhinitis in obese children.
    Wang X; Shen Y; Ke X; Kang H; Hong S
    Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111127. PubMed ID: 35468486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell immunoprofiling after immunotherapy for allergic rhinitis reveals functional suppression of pathogenic T
    Iinuma T; Kiuchi M; Hirahara K; Kurita J; Kokubo K; Yagyu H; Yoneda R; Arai T; Sonobe Y; Fukuyo M; Kaneda A; Yonekura S; Nakayama T; Okamoto Y; Hanazawa T
    J Allergy Clin Immunol; 2022 Oct; 150(4):850-860.e5. PubMed ID: 35863510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Blocking NLRP3 Inflammasome on Type II Innate Lymphoid Cell Response in Allergic Rhinitis.
    Gong G; Huang P; Yang C; Huang C; Zhang Z; Chen R; Sun T; Yang G
    Iran J Immunol; 2023 Sep; 20(3):287-302. PubMed ID: 37583131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in children with allergic rhinitis and the change of TGF-β and IL-13 mRNA level].
    Wu YJ; Wang P; Liu ZX; Qiu SQ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 32(4):256-259. PubMed ID: 29798500
    [No Abstract]   [Full Text] [Related]  

  • 39. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
    Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
    [No Abstract]   [Full Text] [Related]  

  • 40. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.